The gain-of-function mutations of IDH1 and IDH2 genes commonly occur in GBM and acute myeloid leukemia (AML) and are associated with accelerated tumor cell proliferation and inhibited differentiation [75,76]. The gene discussed is IDH2; the disease is acute myeloid leukemia.